A-A-54392
30 April 1991
COMMERCIAL ITEM DESCRIPTION
HYDROXYPROGESTERONE CAPROATE INJECTION, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-H-37423 which is cancelled.
Salient characteristics.
Shall be Hydroxyprogesterone Caproate Injection, USP.
Shall be in accordance with the requirement of the USP.
All ingredients shall be of a pharmaceutical grade.
Strength:
1. 125 mg/ml.
2. 250 mg/ml.
Shall contain the labeled amount of Hydroxyprogesterone per ml within the applicable assay limits for the injection.
Workmanship. The injection shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Vial (VI).
For Size I - One vial containing 5 ml, as specified, constitutes one unit.
For Size II - One vial containing 10 ml, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business